scispace - formally typeset
Open AccessJournal ArticleDOI

Clinical Cancer Nanomedicine.

Joy Wolfram, +1 more
- 01 Apr 2019 - 
- Vol. 25, pp 85-98
Reads0
Chats0
TLDR
Successful clinically approved cancer nanodrugs as well as promising candidates in the pipeline are discussed, categorized according to whether they predominantly exploit multifunctionality, unique electromagnetic properties, or distinct transport characteristics in the body.
About
This article is published in Nano Today.The article was published on 2019-04-01 and is currently open access. It has received 285 citations till now. The article focuses on the topics: Nanomedicine & Drug delivery.

read more

Citations
More filters
Journal ArticleDOI

Insights from nanomedicine into chloroquine efficacy against COVID-19.

TL;DR: Chloroquine — an approved malaria drug — is known in nanomedicine research for the investigation of nanoparticle uptake in cells, and may have potential for the treatment of COVID-19.
Journal ArticleDOI

Extracellular vesicle-based drug delivery systems for cancer treatment

TL;DR: This review gives an overview of EV-based drug delivery strategies in cancer therapy and finds them promising for drug delivery applications.
Journal ArticleDOI

Nanomaterials for Nanotheranostics: Tuning Their Properties According to Disease Needs.

TL;DR: This review meticulously and critically examines the applications of nanotheranostics with various nanomaterials, including graphene, across several diseases; offering a broader perspective of this emerging field.
Journal ArticleDOI

Supramolecular cancer nanotheranostics

TL;DR: In this paper, the authors summarized the progress of supramolecular cancer nanotheranostics and provided guidance for designing new targeted theranostic agents based on extensive state-of-the-art research.
Journal ArticleDOI

Cancer therapy with iron oxide nanoparticles: Agents of thermal and immune therapies.

TL;DR: Clinical applications of iron oxide nanoparticles present poignant case studies of the opportunities, complexities, and challenges in cancer nanomedicine and illustrate the need for revised paradigms and multidisciplinary approaches to develop and translate nanomediines into clinical cancer care.
References
More filters
Journal Article

A New Concept for Macromolecular Therapeutics in Cancer Chemotherapy: Mechanism of Tumoritropic Accumulation of Proteins and the Antitumor Agent Smancs

TL;DR: It is speculated that the tumoritropic accumulation of smancs and other proteins resulted because of the hypervasculature, an enhanced permeability to even macromolecules, and little recovery through either blood vessels or lymphatic vessels in tumors of tumor-bearing mice.
Journal ArticleDOI

Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3.

TL;DR: It is shown that mammalian TLR3 recognizes dsRNA, and that activation of the receptor induces the activation of NF-κB and the production of type I interferons (IFNs).
Journal ArticleDOI

Minimal information for studies of extracellular vesicles 2018 (MISEV2018) : a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines

Clotilde Théry, +417 more
TL;DR: The MISEV2018 guidelines include tables and outlines of suggested protocols and steps to follow to document specific EV-associated functional activities, and a checklist is provided with summaries of key points.
Journal ArticleDOI

Fibroblasts in cancer

TL;DR: Fibroblasts are a key determinant in the malignant progression of cancer and represent an important target for cancer therapies.
Journal ArticleDOI

Renal clearance of quantum dots.

TL;DR: This study has precisely defined the requirements for renal filtration and urinary excretion of inorganic, metal-containing nanoparticles and provides a foundation for the design and development of biologically targeted nanoparticles for biomedical applications.
Related Papers (5)